Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.

Kabel AM, Atef A, Estfanous RS

Open source

DOI
10.1016/j.biopha.2017.10.149
Published
2018 Jan
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2017.10.149,
  title = {Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.},
  author = {Kabel AM and Atef A and Estfanous RS},
  year = {2018},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2017.10.149},
  url = {https://doi.org/10.1016/j.biopha.2017.10.149}
}

RIS

TY  - JOUR
TI  - Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.
AU  - Kabel AM
AU  - Atef A
AU  - Estfanous RS
PY  - 2018
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2017.10.149
UR  - https://doi.org/10.1016/j.biopha.2017.10.149
ER  - 

APA

AM, K., A, A., & RS, E. (2018). Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2017.10.149

Source records